Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Rating of "Buy" from Brokerages

Shares of Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) have been given a consensus recommendation of "Buy" by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have issued a buy rating and two have issued a strong buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $138.8889.

Several research analysts have issued reports on the company. Stephens reiterated an "overweight" rating and set a $140.00 price objective on shares of Addus HomeCare in a research note on Wednesday, September 3rd. Royal Bank Of Canada increased their target price on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a research report on Friday, August 22nd. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. UBS Group assumed coverage on shares of Addus HomeCare in a research note on Tuesday, September 2nd. They set a "buy" rating and a $145.00 price objective on the stock. Finally, Barclays lifted their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the company an "underweight" rating in a research note on Tuesday, August 19th.

Addus HomeCare Price Performance

NASDAQ ADUS traded down $2.11 during trading on Monday, reaching $110.27. 86,255 shares of the company traded hands, compared to its average volume of 118,442. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a market cap of $2.03 billion, a price-to-earnings ratio of 24.34, a P/E/G ratio of 1.71 and a beta of 0.85. The stock's 50 day moving average price is $111.98 and its two-hundred day moving average price is $107.13. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. The business had revenue of $349.44 million during the quarter, compared to analysts' expectations of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare's quarterly revenue was up 21.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.35 EPS. As a group, analysts anticipate that Addus HomeCare will post 4.59 EPS for the current year.

Insider Activity at Addus HomeCare

In other news, EVP Brian Poff sold 7,739 shares of the firm's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the sale, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. This trade represents a 11.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Veronica Hill-Milbourne sold 1,571 shares of Addus HomeCare stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the transaction, the director directly owned 5,067 shares of the company's stock, valued at $582,350.31. This represents a 23.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock valued at $3,958,375 in the last three months. Corporate insiders own 4.50% of the company's stock.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors have recently modified their holdings of the stock. Thrivent Financial for Lutherans grew its stake in shares of Addus HomeCare by 1.4% during the second quarter. Thrivent Financial for Lutherans now owns 13,350 shares of the company's stock valued at $1,538,000 after purchasing an additional 179 shares during the last quarter. State of Wyoming acquired a new position in Addus HomeCare during the 2nd quarter worth $47,000. Public Sector Pension Investment Board boosted its position in Addus HomeCare by 9.0% in the 2nd quarter. Public Sector Pension Investment Board now owns 61,934 shares of the company's stock valued at $7,134,000 after buying an additional 5,098 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its position in Addus HomeCare by 0.6% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company's stock valued at $2,150,000 after buying an additional 106 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its stake in shares of Addus HomeCare by 299.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,563 shares of the company's stock valued at $180,000 after buying an additional 1,172 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.